Inventor
SHAH NAVNIT HARGOVINDAS
US18 patents
⚠️ This page may combine multiple inventors who share the name “SHAH NAVNIT HARGOVINDAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
15 patentsUS7014866B2Mar 21, 2006
High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same
HOFFMANN LA ROCHE151 citations98
US6350786B1Feb 26, 2002
Stable complexes of poorly soluble compounds in ionic polymers
HOFFMANN LA ROCHE94 citations96
US6039975AMar 21, 2000
Colon targeted delivery system
HOFFMANN LA ROCHE522 citations96
US6004996ADec 21, 1999
Tetrahydrolipstatin containing compositions
HOFFMANN LA ROCHE167 citations94
US6486329B1Nov 26, 2002
Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
HOFFMANN LA ROCHE10 citations72
US10034854B2Jul 31, 2018
Pharmaceutical composition with improved bioavailability
HOFFMANN LA ROCHE3 citations68
US6492530B1Dec 10, 2002
Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
HOFFMANN LA ROCHE2 citations61
US6482847B2Nov 19, 2002
Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
HOFFMANN LA ROCHE1 citations61
US6469179B1Oct 22, 2002
Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
HOFFMANN LA ROCHE2 citations61
US11185588B2Nov 30, 2021
Pharmaceutical dosage forms comprising valganciclovir hydrochloride
HOFFMANN LA ROCHE0 citations58
US9427427B2Aug 30, 2016
Pharmaceutical composition with improved bioavailability
HOFFMANN LA ROCHE2 citations57
US6469180B1Oct 22, 2002
Amorphous form of cell inhibitor having improved solubility and bioavailability
HOFFMANN LA ROCHE0 citations51
US9642911B2May 9, 2017
Pharmaceutical dosage forms comprising valganciclovir hydrochloride
HOFFMANN LA ROCHE0 citations47
US8889109B2Nov 18, 2014
Pharmaceutical dosage forms comprising valganciclovir hydrochloride
HOFFMANN LA ROCHE1 citations47
US8852634B2Oct 7, 2014
Dosage formulation
HOFFMANN LA ROCHE0 citations31